dsm-firmenich announces results of extraordinary general meeting of shareholders

Kaiseraugst (Switzerland), Heerlen (Netherlands), June 29, 2023

dsm-firmenich, innovators in nutrition, health, and beauty, confirms that all resolutions on the agenda of today’s extraordinary general meeting were approved by shareholders:

Approval of the stand-alone interim financial statements of DSM-Firmenich AG for the period from 1 January 2023 to 8 May 2023
Approval of a dividend of EUR 1.60 per share to the shareholders of DSM-Firmenich AG
Approval of the remuneration for the members of the Board of Directors and the Executive Committee
Approval of certain changes to the Articles of Association

Details of the extraordinary general meeting can be found at https://www.dsm-firmenich.com/corporate/investors/corporate-governance/egm.html

For more information:

dsm-firmenich investor relations enquiries:
email: investors@dsm-firmenich.com

dsm-firmenich media enquiries:
email: media@dsm-firmenich.com

Forward-looking statements

This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.